Douglas Tsao
Stock Analyst at HC Wainwright & Co.
(0.78)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ROIV Roivant Sciences | Reiterates: Buy | 18 18 | 11.51 | 56.39% | 20 | Jun 18, 2025 | |
SAGE Sage Therapeutics | Reiterates: Neutral | 12 12 | 9.29 | 29.17% | 23 | Jun 17, 2025 | |
IRON Disc Medicine | Reiterates: Buy | 118 118 | 51.62 | 128.59% | 15 | Jun 17, 2025 | |
CABA Cabaletta Bio | Reiterates: Buy | 25 25 | 1.75 | 1328.57% | 26 | Jun 11, 2025 | |
ARGX argenx | Reiterates: Buy | 720 720 | 540.88 | 33.12% | 38 | Jun 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 53.35 | 49.95% | 33 | Jun 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 53 53 | 31.47 | 68.41% | 5 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 105 105 | 41.79 | 151.26% | 23 | May 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 7 7 | 0.73 | 858.9% | 25 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 14 14 | 4.03 | 247.39% | 17 | Apr 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 34 34 | 14.68 | 131.61% | 16 | Apr 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 27 27 | 9.39 | 187.54% | 27 | Apr 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 19 19 | 14.4 | 31.94% | 4 | Apr 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 2.55 | 370.59% | 17 | Apr 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 18 18 | 3.81 | 372.44% | 14 | Mar 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 51 51 | 15.46 | 229.88% | 22 | Mar 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 18 18 | 0.75 | 2300% | 7 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 54 54 | 14.43 | 274.22% | 14 | Mar 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 57 57 | 17.64 | 223.13% | 26 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 10.56 | 42.05% | 15 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 5 5 | 1.81 | 176.24% | 14 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 3 | 1.69 | 77.51% | 16 | Feb 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 46 46 | 29.24 | 57.32% | 23 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 81 81 | 29.84 | 171.45% | 23 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 5 5 | n/a | n/a | 10 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | n/a | n/a | 19 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 7 7 | n/a | n/a | 19 | Nov 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 3.81 | 109.97% | 9 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 360 360 | n/a | n/a | 8 | Oct 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 41 45 | n/a | n/a | 6 | Dec 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | n/a | n/a | 2 | Aug 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 6 | n/a | n/a | 3 | Mar 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Jan 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 74 | n/a | n/a | 1 | Nov 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 10 | 1.12 | 792.86% | 5 | Jun 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 48 30 | n/a | n/a | 2 | Mar 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | n/a | n/a | 1 | Dec 23, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 23 10 | 29.64 | -66.26% | 7 | Dec 9, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 162 220 | n/a | n/a | 5 | Feb 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 14 | n/a | n/a | 6 | Oct 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 53 | n/a | n/a | 9 | Aug 25, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 10 | n/a | n/a | 7 | Aug 12, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 168 182 | 147.41 | 23.47% | 4 | Feb 20, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 19 | 6.41 | 192.51% | 2 | Jan 23, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 25 18 | 24.41 | -26.26% | 3 | Aug 29, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | n/a | n/a | 5 | Aug 28, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underweight | 8 | 16.96 | -52.83% | 7 | Jun 11, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 26 | n/a | n/a | 3 | Jun 11, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 52 | 24.67 | 110.78% | 2 | Jun 11, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 34 0 | n/a | n/a | 6 | Jun 6, 2018 |